Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 402 participants.

Also called NCT01456949

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 402 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01456949
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01456949. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06-26 (actual); primary completion 2017-11-30 (actual). Results posted on 2019-01-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
Acronym
STOP AF PAS
Condition
Paroxysmal Atrial Fibrillation (PAF)
Intervention (Device)
Medtronic Arctic Front® Cardiac CryoAblation System
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct01456949
Content hash
2c5f84a5171851cd15c8873cbacee1d28b67428b7d1bd377ddab7317a6fb7038